Table 1 Age and gender specific proportion of total population in Greenland tested with HbA1c during 2014 or 2015 and estimated prevalence of diagnosed diabetes and pre-diabetes

16.6

5.5

28.4

<0.001

2.5

1.2

3.9

<0.001

0.5

0.4

0.6

0.097

(16.6–17.2)

(5.1–5.9)

(27.4–29.4)

(−38.9)

(2.3–2.8)

(1.0–1.5)

(3.5–4.4)

(−11.0)

(0.4–0.6)

(0.2–0.59

(0.4–0.7)

(−1.7)

(2671/16,060)

(459/8272)

(2212/7788)

(408)

(101)

(307)

(74)

(31)

(43)

18.4

12.0

26.0

<0.001

5.5

3.6

7.7

<0.001

2.1

1.9

2.4

0.159

(17.5–19.2)

(11.0–12.9)

(24.6–27.4)

(−16.4)

(5.0–6.0)

(3.1–4.2)

(6.9–8.6)

(−8.1)

(1.8–2.4)

(1.5–2.3)

(1.9–2.9)

(−1.4)

(1516/8251)

(538/4488)

(978/3763)

(452)

(162)

(290)

(175)

(86)

(89)

28.6

22.7

36.0

<0.001

10.4

7.6

13.8

<0.001

6.4

5.5

7.6

<0.001

(27.7–29.6)

(21.5–23.9)

(34.5–37.5)

(−13.8)

(9.7–11.0)

(6.9–8.4)

(12.7–14.8)

(−9.4)

(5.9–6.9)

(4.8–6.1)

(6.8–8.4)

(−4.0)

(2523/8807)

(1103/4864)

(1420/3943)

(913)

(370)

(543)

(556)

(267)

(299)

40.0

36.3

45.1

<0.001

13.6

10.8

17.4

<0.001

12.3

11.9

12.8

0.359

(38.6–41.4)

(34.5–38.2)

(42.8–47.4)

(25.4)

(12.6–14.6)

(9.6–12.0)

(15.7–19.1)

(−6.3)

(11.3–13.3)

(10.7–13.2)

(11.3–14.4)

(−0.9)

(1784/4460)

(941/2591)

(843/1869)

(605)

(280)

(325)

(549)

(309)

(240)

50.1

51.0

49.2

0.412

15.3

14.2

16.5

0.148

16.5

17.1

15.9

0.003

(47.9–52.3)

(48.0–54.1)

(46.1–52.3)

(0.8)

(13.7–16.9)

(12.1–16.3)

(14.2–18.8)

(−1.4)

(14.9–18.1)

(14.8–19.4)

(13.6–18.2)

(−3.0)

(1012/2019)

(529/1037)

(483/982)

(309)

(147)

(162)

(333)

(117)

(156)

24.0

16.8

32.4

<0.001

6.8

5.0

8.9

<0.001

4.3

4.1

4.5

0.042

(23.6–24.4)

(16.3–17.3)

(31.7–33.0)

(−36.1)

(6.5–7.0)

(4.7–5.3)

(8.5–9.3)

(−15.3)

(4.1–4.5)

(3.8–4.4)

(4.2–4.8)

(−2.0)

(9506/39,597)

(3570/21,252)

(5936/18,345)

(2824)

(1060)

(1627)

(1687)

(870)

(827)